Granite Investment Partners’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.1M | Sell |
124,462
-8,667
| -7% | -$985K | 0.69% | 52 |
|
|
2025
Q1 | $14M | Buy |
133,129
+17,591
| +15% | +$1.85M | 0.71% | 51 |
|
|
2024
Q4 | $12.4M | Sell |
115,538
-2,463
| -2% | -$264K | 0.54% | 65 |
|
|
2024
Q3 | $11.8M | Buy |
+118,001
| New | +$11.8M | 0.51% | 73 |
|
|
2021
Q1 | – | Sell |
-59,173
| Closed | -$3.67M | – | 283 |
|
|
2020
Q4 | $3.67M | Sell |
59,173
-96,578
| -62% | -$5.99M | 0.13% | 149 |
|
|
2020
Q3 | $9.26M | Sell |
155,751
-165,500
| -52% | -$9.84M | 0.41% | 95 |
|
|
2020
Q2 | $22.4M | Buy |
321,251
+264,766
| +469% | +$18.5M | 1.08% | 25 |
|
|
2020
Q1 | $2.56M | Buy |
56,485
+18,298
| +48% | +$830K | 0.17% | 135 |
|
|
2019
Q4 | $2.48M | Buy |
38,187
+14,217
| +59% | +$925K | 0.12% | 179 |
|
|
2019
Q3 | $1.49M | Sell |
23,970
-160
| -0.7% | -$9.93K | 0.08% | 194 |
|
|
2019
Q2 | $1.72M | Sell |
24,130
-69,437
| -74% | -$4.94M | 0.09% | 167 |
|
|
2019
Q1 | $7.34M | Buy |
93,567
+85,823
| +1,108% | +$6.73M | 0.42% | 86 |
|
|
2018
Q4 | $656K | Buy |
+7,744
| New | +$656K | 0.05% | 221 |
|
|
2018
Q2 | – | Sell |
-132,459
| Closed | -$13.6M | – | 326 |
|
|
2018
Q1 | $13.6M | Sell |
132,459
-3,152
| -2% | -$325K | 0.91% | 40 |
|
|
2017
Q4 | $11.6M | Sell |
135,611
-52,575
| -28% | -$4.49M | 0.73% | 60 |
|
|
2017
Q3 | $16M | Buy |
188,186
+9,570
| +5% | +$813K | 0.99% | 27 |
|
|
2017
Q2 | $13.5M | Buy |
178,616
+15,209
| +9% | +$1.15M | 0.91% | 31 |
|
|
2017
Q1 | $10.8M | Buy |
163,407
+33,057
| +25% | +$2.18M | 0.74% | 54 |
|
|
2016
Q4 | $8.26M | Sell |
130,350
-5,307
| -4% | -$336K | 0.61% | 74 |
|
|
2016
Q3 | $8.64M | Buy |
135,657
+21,166
| +18% | +$1.35M | 0.64% | 63 |
|
|
2016
Q2 | $8.52M | Buy |
114,491
+25,092
| +28% | +$1.87M | 0.67% | 51 |
|
|
2016
Q1 | $5.97M | Sell |
89,399
-419
| -0.5% | -$28K | 0.54% | 65 |
|
|
2015
Q4 | $6.08M | Buy |
+89,818
| New | +$6.08M | 0.55% | 76 |
|